2021 Conference Publication Acute compartment syndrome following heart transplantBayat, M. Khorramshahi, Chan, W., Javorsky, G., Platts, D., Dashwood, A., Wong, Y., Mulligan, A., Tesar, P., Prahbu, A., Thomson, B., Lavana, J. and McKenzie, S. (2021). Acute compartment syndrome following heart transplant. ISHLT2021 Annual Meeting and Scientific Sessions, Virtual, 24-28 April 2021. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.healun.2021.01.585 |
2021 Conference Publication High Pre-Donation Vasoactive Inotropic Score (VIS) May Be Associated with Increased Risk of Primary Graft Dysfunction in Cardiac TransplantationChalla, A., Maddicks-Law, J., Mulligan, A., Prabhu, A. and Wong, Y. (2021). High Pre-Donation Vasoactive Inotropic Score (VIS) May Be Associated with Increased Risk of Primary Graft Dysfunction in Cardiac Transplantation. ISHLT2021 41st Annual Meeting & Scientific Sessions, Online, 24-28 April 2021. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2021.01.653 |
2021 Journal Article Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fractionDashwood, Alexander, Vale, Cassandra, Laher, Shaaheen, Chui, Fiona, Hay, Karen and Wong, Yee Weng (2021). Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction. Journal of Clinical Pharmacology, 61 (4), 515-521. doi: 10.1002/jcph.1754 |
2020 Journal Article A rare case of severe nontropical isolated right ventricular endomyocardial fibrosisLaher, Shaaheen, Wong, Yee Weng, Platts, David, Prabhu, Anil, Thomson, Bruce, Hamilton-Craig, Christian, Godbolt, David, Cheesman, Elizabeth and Dashwood, Alexander (2020). A rare case of severe nontropical isolated right ventricular endomyocardial fibrosis. JACC: Case Reports, 2 (13), 2078-2084. doi: 10.1016/j.jaccas.2020.09.042 |
2020 Journal Article Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”Dashwood, Alexander, Beard, Nicole, Wong, Yee Weng, Haqqani, Haris, Cheesman, Elizabeth and Molenaar, Peter (2020). Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”. ACS Pharmacology and Translational Science, 3 (6), 1422-1422. doi: 10.1021/acsptsci.0c00148 |
2020 Journal Article Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failureDashwood, Alexander, Cheesman, Elizabeth, Beard, Nicole, Haqqani, Haris, Wong, Yee Weng and Molenaar, Peter (2020). Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure. ACS Pharmacology and Translational Science, 3 (4) acsptsci.0c00003, 563-582. doi: 10.1021/acsptsci.0c00003 |
2020 Journal Article Impact of patient and model of care factors on titration and tolerability of sacubitril/valsartan: an early Australian real-world experienceDashwood, Alexander, Vale, Cassandra, Laher, Shaaheen, Chui, Fiona, Rheault, Haunnah, Gan, Jaclyn and Wong, Yee Weng (2020). Impact of patient and model of care factors on titration and tolerability of sacubitril/valsartan: an early Australian real-world experience. Heart, Lung and Circulation, 29 (11), 1688-1695. doi: 10.1016/j.hlc.2020.03.008 |
2020 Conference Publication Determining the properties of omecamtiv mecarbil on human explanted cardiac trabeculae and its interaction with current inotropes via the beta 1-adrenoceptorDashwood, A., Cheesman, E., Wong, Y., Haqqani, H. and Molenaar, P. (2020). Determining the properties of omecamtiv mecarbil on human explanted cardiac trabeculae and its interaction with current inotropes via the beta 1-adrenoceptor. 40th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation (ISHLT), Montreal, QC, Canada, 22 - 25 April 2020. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.healun.2020.01.427 |
2020 Conference Publication Return of the MRA: Comparative Tolerability and Safety of ARNI With MRA Co-Prescription in HFrEFVale, C., Dashwood, A., Hay, K., Laher, S., Chui, F. and Wong, Y. (2020). Return of the MRA: Comparative Tolerability and Safety of ARNI With MRA Co-Prescription in HFrEF. 68th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 14th Annual Australia and New Zealand Endovascular Therapies Meeting, Online, 11–13 December 2020. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2020.09.169 |
2019 Journal Article Orthotopic cardiac transplantation for Chagas cardiomyopathy in AustraliaRausch, Karen, Lau, Katherine, Ulett, Kimberly, Chan, Wandy, Javorsky, George, Wong, Yee W., Thompson, Bruce, Pauli, John, McKenzie, Scott, Horvath, Robert and Platts, David (2019). Orthotopic cardiac transplantation for Chagas cardiomyopathy in Australia. Internal Medicine Journal, 49 (9), 1194-1195. doi: 10.1111/imj.14421 |
2019 Conference Publication Hypophosphataemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failureDashwood, A., Chui, F., Laher, S., Vale, C., Chan, W., McKenzie, S. and Wong, Y. (2019). Hypophosphataemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure. 67th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 13th Annual Australia and New Zealand Endovascular Therapies Meeting, Adelaide, SA Australia, 8-11 August 2019. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2019.06.094 |
2019 Conference Publication Translation of clinical trial to real world practice: can sacubitril-valsartan be safely titrated to target dose, 97/103mg bi-daily, in clinical practice and what baseline characteristics predict successful titration?Dashwood, Alexander, Vale, Cassandra, Laher, Shaaheen, Rheault, Haunnah, Mckenzie, Scott and Wong, Yee Weng (2019). Translation of clinical trial to real world practice: can sacubitril-valsartan be safely titrated to target dose, 97/103mg bi-daily, in clinical practice and what baseline characteristics predict successful titration?. 68th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), New Orleans, LA, United States, 16-18 March 2019. San Diego, CA, United States: Elsevier. doi: 10.1016/s0735-1097(19)31312-9 |
2018 Journal Article Effects of once-weekly exenatide on clinical outcomes in patients with preexisting cardiovascular disease: prespecified analysis from EXSCELMentz, Robert J., Thompson, Vivian P., Aguilar, David, Choi, Jasmine, Gustavson, Stephanie M., Iqbal, Nayyar, Kong, Alice P., Ohman, Peter, Sattar, Naveed, Scott, Russell S., Wong, Yee Weng, Holman, Rury R. and Hernandez, Adrian F. (2018). Effects of once-weekly exenatide on clinical outcomes in patients with preexisting cardiovascular disease: prespecified analysis from EXSCEL. Circulation, 138 (22), 2576-2578. doi: 10.1161/CIRCULATIONAHA.118.036811 |
2018 Journal Article Right heart catheterisation: how to do itKrishnan, Anish, Markham, Ryan, Savage, Michael, Wong, Yee-Weng and Walters, Darren (2018). Right heart catheterisation: how to do it. Heart Lung and Circulation, 28 (4), 1-8. doi: 10.1016/j.hlc.2018.08.005 |
2018 Conference Publication Single-Centre Experience of Durable Bi-Ventricular Support with HeartWare Continuous Flow, Centrifugal Ventricular Assist Devices (HeartWare BiVADs)Dashwood, A., Laher, S., Wang, C., Prabhu, A., Tesar, P., Ziegenfuss, M., Wong, Y., Javorsky, G., Smith, I., Platts, D., Chan, W., McKenzie, S., Bancroft, J., Maddicks-Law, J. and Thomson, B. (2018). Single-Centre Experience of Durable Bi-Ventricular Support with HeartWare Continuous Flow, Centrifugal Ventricular Assist Devices (HeartWare BiVADs). 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2-5 August 2018. Chatswood, NSW Australia: Elsevier . doi: 10.1016/j.hlc.2018.06.196 |
2018 Conference Publication Validation of EUROMACS-RHF (European Registry for Patients with Mechanical Circulatory Support Right-Sided Heart Failure) Score in Predicting Early Right Heart Failure Following Left Ventricular Assist Device Insertion in an Australian Single-Centre CohortDashwood, A., Laher, S., Menon, N., Thomson, B., Prabhu, A., Tesar, P., Ziegenfuss, M., Smith, I., Javorsky, G., Platts, D., McKenzie, S., Chan, W., Bancroft, J., Maddicks-Law, J. and Wong, Y. (2018). Validation of EUROMACS-RHF (European Registry for Patients with Mechanical Circulatory Support Right-Sided Heart Failure) Score in Predicting Early Right Heart Failure Following Left Ventricular Assist Device Insertion in an Australian Single-Centre Cohort. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2–5 August 2018. Chatswood, NSW Australia: Elsevier . doi: 10.1016/j.hlc.2018.06.223 |
2018 Conference Publication Combining forces: nurse practitioner and clinical pharmacist led heart failure clinic and its impact on titration rates and hospital readmissionRheault, H., Gan, J., McKenzie, S. and Wong, Y. (2018). Combining forces: nurse practitioner and clinical pharmacist led heart failure clinic and its impact on titration rates and hospital readmission. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2-5 August 2018. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2018.06.100 |
2018 Conference Publication Gender differences in patient characteristics and quality-of-care indicators among referrals to Queensland statewide heart failure support servicesWong, Y., Hickey, A., Nunan, T., Adsett, J., Denaro, C., Peters, R. and Atherton, J. (2018). Gender differences in patient characteristics and quality-of-care indicators among referrals to Queensland statewide heart failure support services. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, Australia, 2-5 August 2018. Chatswood, NSW, Australia: Elsevier . doi: 10.1016/j.hlc.2018.06.137 |
2018 Conference Publication Explant of heartware biventricular assist devices following myocardial recovery after peripartum cardiomyopathyLau, K., Bancroft, J., McKenzie, S., Javorsky, G., Chan, W., Wong, Y., Thomson, B., Prabhu, A., Fraser, J. and Platts, D. (2018). Explant of heartware biventricular assist devices following myocardial recovery after peripartum cardiomyopathy. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2-5 August 2018. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2018.06.126 |
2018 Conference Publication Early real-world experience of tolerability and titration rates of angiotensin-receptor-neprilysin inhibitorVale, C., Gan, J., McKenzie, S., Wong, Y., Rheault, H., Laher, S. and Dashwood, A. (2018). Early real-world experience of tolerability and titration rates of angiotensin-receptor-neprilysin inhibitor. Abstracts for the 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2-5 August 2018. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2018.06.117 |